• Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
  • Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
  • Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
  • Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
  • Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
  • Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price

Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: White Powder
Purity: >99%
Samples:
US$ 50/Bag 1 Bag(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory
Gold Member Since 2021

Suppliers with verified business licenses

Shaanxi, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (10)

Basic Info.

Model NO.
Frazer-Niraparib
Appearance
White Powder
Shelf Life
2 Years
Storage
Store in a Well-Closed Container Away From Moistur
Delivery
Express 5-7 Days Arrive
Test Method
HPLC
Assay
99%
MOQ
1kg
Mf
C25h32f3n3o4
MW
495.53
CAS
1038915-60-4
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
200kg Per Month

Product Description

Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price

What is Niraparib?

Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.

Fuction and Application of Niraparib

Niraparib  is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer..
The drug is approved by the US FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.


Strenghths of Our Products:
 

1) Living with chemical innovation;
2) Equipped with the professional quality testing equipment & conscience of the field.
3) Most competitive price and mostly welcomed by foreign customers from North America, Europe, the Middle East, etc.
4) Highly pure and salfe and can be applied in various fields.

Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price
Pharmaceutical Raw Material Niraparib Powder CAS 1038915-60-4 with Best Price

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters